期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

利钠肽在急性心力衰竭预后评估及指导治疗中的作用 被引量：5

Utility of Natriuretic Peptides Testing in the Evaluation and Management of Acute Heart Failure
原文传递
导出
摘要 利钠肽(BNP与NT-proBNP)是预测急性心衰预后及评估急性心衰治疗效果可靠的指标。日常临床决策加用利钠肽检测提高了急性心衰高危患者的发现率,而这些患者往往需要加强追踪及强化治疗。现就利钠肽在评估急性心衰预后及指导心衰治疗中的价值作如下综述。 Natriuretic peptides（B-type natriuretic peptide （BNP） and N-terminal pro-B-type natriuretic peptide （NT-pro-BNP）） are reliable tools for establishing prognosis and evaluating the effectiveness of treatment of acutely heart failure.The addition of BNP and NT-proBNP to usual clinical decision making enhances detection of high-risk patients who need aggressive follow-up and adjustment of treatment, we present an overview of the value of natriuretic peptides in the context of acute heart failure prognosis and treatment therapy optimization.
作者 李航顺 梁兆光
机构地区 哈尔滨医科大学附属第一医院心血管内科
出处 《现代生物医学进展》 CAS 2012年第26期5198-5200,5159,共4页 Progress in Modern Biomedicine
关键词 急性心衰 利钠肽 预后 治疗最优化 Acute heart failure Natriuretic peptide Prognosis Treatment therapy optimization
分类号 R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献23

  • 1Adams KF, Lindenfeld J, Arnold JMO, et al. Executive summary:HFSA 2006 comprehensive heart failure practice guideline[J]. J Card Fail, 2006, 12:10-38.
  • 2Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guide-line update for the diagnosis and management of chronic heart failure in the adult: a report of the American college of cardiology/American heart association task force on practice guide-lines [J]. Circulation, 2005, 112:e154-e235.
  • 3顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量：1277
  • 4Lee DS, Austin PC, Rouleau JL,et al. Predicting mortality among patients hospitalized for or heart failure: derivation and validation of a clinical model[J]. J Am Med Assoc,2003, 290:2581-2587.
  • 5Mohammed AA, Januzzi JL, Jr. Natriuretic peptide guided heart failure management[J]. Curr Clin Pharmacol, 2009, 4:87-94.
  • 6Cowie MR, Struthers AD, Wood DA, et al. Value ofnatriuretic peptides in assessment of patients with possible new heart failure in primary care[J]. Lancet, 1997, 350:1347-1351.
  • 7Braunwald E. Biomarkers in heart failure [J]. NEJM, 2008, 358:2148 -2159.
  • 8Baggish AL, Kimmenade RR, Januzzi JL. Amino-terminal Pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure [J]. Am J Cardiol, 2008, 101 (suppl):49-55.
  • 9Braunschweig F, Fahrleitner-Pammer A, Mangiavacchi M, et al. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure[J]. Eur J Heart Fail, 2006, 8:797-803.
  • 10Troughton RW, Richards AM. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal Pro-B-type natriuretic peptide measurement[J]. Am J Cardiol, 2008,101 (suppl):72A-75A.

二级参考文献1

  • 1叶任高 主编.内科学:第5版[M].北京:人民卫生出版社,2001.824.

共引文献1276

同被引文献58

  • 1于佳慧,王岚峰.慢性心力衰竭中胃肠系统变化的意义[J].世界华人消化杂志,2006,14(17):1721-1725. 被引量：19
  • 2de Bold AJ, Borenstein HB, Veress AT, et al. Arapid and potent natri- uretie response to intravenous injection of atrial myocardial extract in rats [J]. Life Sci, 1981, 28(1): 89-94.
  • 3Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain [J]. Nature, 1988, 332(6159): 78-81.
  • 4Saito Y, Nakao K, Itoh H, et al. Brain natriuretic peptide is a novelcardiac hormone [J]. Biochem Biophys Res Commun, 1989, 158 (2): 360-368.
  • 5Sudoh T, Minamino N, Kangawa K, et aL C-typenatriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain [J]. Biochem Biophys Res Commun, 1990, 168(2): 863-870.
  • 6Goetze JP, Hausen LH, Terzic D, et al. Atrial natrinretic peptides in plasma [J]. Clin Chim Acta, 2015, 443: 25-28.
  • 7Mohammed AA, Januzzi JL Jr. Natriuretic peptide guided heart fail- ure management [J]. Curr Clin Pharmacol, 2009, 4: 87-94.
  • 8Stryjewski PJ, Nessler B, Cubera K, et al. Natriuretic peptides. His- tory of discovery, chemical structure, mechanism of action and the removal routes. Basis of diagnostic and therapeutic use [J]. Przegl Lek, 2013, 70(7): 463-467.
  • 9Takushima S, Nishi Y, Nonoshita A, et al. Changes in the nitric ox- ide-soluble guanylate cyclase system and natriuretic peptide recep- tor system in placentas of pregnant Dalai salt-sensitive rats [Y]. J Ob- stet Gynaecol Res, 2015, 41(4): 540-550.
  • 10Park BM, Oh YB, Gao S, et al. Angioteusin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor [J]. Pepfides, 2013, 42: 131-137.

引证文献5

二级引证文献13

现代生物医学进展
2012年 第26期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部